While the progression of androgen-dependent PC to CRPC likely involves various mechanisms, AR and its signalling have been shown to play important roles in disease development, including the acquisition of acquired resistance to various ADT drugs [330]. This evidence concerns the gene AR and pachyonychia congenita.